Science Explorer Back to mapMap
Discussion
Researcher · Center of Molecular Immunology (Cuba) · Cuba

Ailem Rabasa

Ailem Rabasa publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses and HER2/EGFR in Cancer Research.

ORCID 0000-0002-4250-2725 OpenAlex
World rank
#2,193,532
of 7,710,434 ranked researchers
Rank in Cuba
#114
of 7,334
Works
26
Citations
860
Citations per work
33.1
h-index
10
i10-index 10Top 59% in Oncology
Ailem Rabasa

What does Ailem Rabasa research?

Ailem Rabasa's work is mostly in Medicine (51%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 13 works · 50.9% of their workMedicine: 13 works · 50.9% of their workOncology: 7 works · 27.9% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 23.0% of their workLife Sciences: 9 works · 34.5% of their workImmunology and Microbiology: 5 works · 19.7% of their workImmunology: 5 works · 19.7% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 14.8% of their workMolecular Biology: 3 works · 11.5% of their workGenetics: 1 works · 3.3% of their workEverything else: 3 works · 11.3% of their workPhysical Sciences: 1 works · 3.3% of their workEngineering: 1 works · 3.3% of their workBiomedical Engineering: 1 works · 3.3% of their workTHEIR WORKAilem Rabasa26works
Life Sciences35%Physical Sciences3%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1350.9%
    1. Immunology and Microbiology519.7%
    2. Biochemistry, Genetics and Molecular Biology414.8%
  3. Everything else311.3%
    1. Engineering13.3%
  1. 1Oncology28% of their works
  2. 2Radiology, Nuclear Medicine and Imaging23% of their works
  3. 3Immunology20% of their works
  4. 4Molecular Biology12% of their works
  5. 5Biomedical Engineering3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Ailem Rabasa's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Chemotherapy, Dendritic Cells, Immunity, Breast Cancer, HER2 and Gene Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Fc Receptors121 topic
  2. Therapeutic Antibodies121 topic
  3. Chemotherapy102 topics
  4. Dendritic Cells101 topic
  5. Immunity101 topic
  6. Breast Cancer81 topic
  7. HER281 topic
  8. Gene Therapy73 topics
  9. Immune Checkpoint Blockade41 topic
  10. PD-1 and PD-L141 topic
  11. RNA Interference31 topic
  12. siRNA Delivery31 topic
  13. AAV21 topic
  14. Bacterial Therapy21 topic
  15. Cetuximab21 topic
  16. KRAS Mutations21 topic
  17. Tumor Targeting21 topic
  18. Viral Vectors21 topic

Where does Ailem Rabasa work?

Ailem Rabasa's main affiliation in the publication record is Center of Molecular Immunology (Cuba), Cuba.

How many publications and citations does Ailem Rabasa have?

OpenAlex counts 26 works and 860 citations for Ailem Rabasa, an h-index of 10, ranking #2,193,532 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ailem Rabasa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.